Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled activity mite vaccines for 'barn allergy'.

O D Cuthbert, W D Brighton, R Ayuso

    Annals of Allergy
    |March 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Imaging digital arteries in systemic sclerosis by tomographic 3-dimensional ultrasound.

    Rheumatology international·2020
    Same author

    Transfer-printed micro-LED and polymer-based transceiver for visible light communications.

    Optics express·2019
    Same author

    Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells.

    Vaccine·2014
    Same author

    Influence of pollen level on hospitalizations for asthma.

    Archives of environmental & occupational health·2013
    Same author

    A sea urchin roe tropomyosin-like protein is recognized in vitro by shrimp-allergic individuals.

    Journal of investigational allergology & clinical immunology·2012
    Same author

    Is epitope recognition of shrimp allergens useful to predict clinical reactivity?

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011

    Mite immunotherapy using delayed-release vaccines showed significant symptom improvement in eight of nine subjects. Nasal therapy with mite extracts did not yield similar positive outcomes in this study.

    Area of Science:

    • Allergen immunotherapy
    • Clinical immunology
    • Agricultural entomology

    Background:

    • Mites are common allergens found in agricultural environments.
    • Dust mites, including Tyrophagus longior, Glyciphagus destructor, and Acarus farris, are prevalent in Orkney farm barns.
    • Standardized allergen extracts are crucial for effective immunotherapy.

    Purpose of the Study:

    • To develop and evaluate mite allergen extracts for immunotherapy.
    • To assess the efficacy of delayed-release injectable vaccines versus nasal therapy.
    • To determine the clinical benefit of mite immunotherapy in a local population.

    Main Methods:

    • Isolation and culturing of three mite species: Tyrophagus longior, Glyciphagus destructor, and Acarus farris.
    • Production of bulk mite extracts and standardization of biologic potency.

    Related Experiment Videos

  • Administration of delayed-release vaccines via injection to nine subjects over 2 months.
  • Nasal provocation tests and therapy with aqueous mite solutions in five subjects.

    • Main Results:

    • Injection therapy with delayed-release mite vaccines resulted in significant symptom improvement in 8 out of 9 subjects.
    • Nasal therapy with aqueous mite solutions showed no improvement in 4 out of 5 subjects.
    • Skin prick testing was used to assess initial allergen potency.

    Conclusions:

    • Delayed-release injectable mite vaccines appear to be an effective therapeutic option for mite-sensitive individuals.
    • Nasal administration of mite allergen solutions showed limited efficacy in this study.
    • Further research is warranted to optimize mite immunotherapy protocols.